Results 161 to 167 of about 2,363 (167)

Clinical development plan: 2-Difluoromethylornithine (DFMO)

Journal of Cellular Biochemistry, 1994
openaire   +1 more source

Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas

British Journal of Cancer, 2013
Jason A Zell, Cheryl L ROCK, E W Gerner
exaly  

Levels of Rectal Mucosal Polyamines and Prostaglandin E2 Predict Ability of DFMO and Sulindac to Prevent Colorectal Adenoma

Gastroenterology, 2010
Patricia A Thompson, Betsy C Wertheim, Jason A Zell   +2 more
exaly  

Clinical development plan: 2-difluoromethylornithine (DFMO).

Journal of cellular biochemistry. Supplement, 1995
G J, Kelloff, J A, Crowell, C W, Boone, V E, Steele, R A, Lubet, P, Greenwald, D S, Alberts, J M, Covey, L A, Doody, G G, Knapp   +9 more
openaire   +1 more source

LUNG DISTRIBUTION OF THE CHEMOPREVENTIVE AGENT DIFLUOROMETHYLORNITHINE (DFMO) FOLLOWING ORAL AND INHALATION DELIVERY

Experimental Lung Research, 2004
exaly  

Studies on polyamines in Solanum tuberosum in vitro: Effects of DFMO, DFMA, chlorogenic acid and putrescine on the endogenous distribution of polyamines, tuberization and morphology

Journal of Plant Physiology, 1997
exaly  

Development of eflornithine [difluoromethylornithine, DFMO] has been discontinued

Inpharma Weekly, 2004
openaire   +1 more source